Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
07/2003
07/10/2003WO2003055886A1 Amorphous substance of tricyclic triazolobenzazepine derivative
07/10/2003WO2003055885A1 Novel crystalline tricyclic triazolobenzazepine derivative
07/10/2003WO2003055884A1 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-carboxamide derivatives, their preparation and therapeutic use
07/10/2003WO2003055882A1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors
07/10/2003WO2003055876A1 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
07/10/2003WO2003055868A1 Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as cdc25 phosphatase inhibitors
07/10/2003WO2003055865A1 Quinazolinone derivative
07/10/2003WO2003055525A1 Acid-containing preparations
07/10/2003WO2003055519A1 Medicinal agent and method for curing diseases accompanied with vascular dystonia
07/10/2003WO2003055518A1 Method for curing immunopathosis and medicinal agent for carrying out said method
07/10/2003WO2003055517A1 Method for correcting immune response and medicinal agent
07/10/2003WO2003055513A2 Bacillus subtilis spores to stimulate the immune responses
07/10/2003WO2003055480A1 Products for use in immunosuppressive therapy containing lipoic acid and a calcineurin inhibitor
07/10/2003WO2003055477A1 Method for the treatment of mc receptor related disorders with a chelate and/or a chelator
07/10/2003WO2003055463A1 Composition comprising at least an oxazolin for inhibiting langerhans cell migration, and uses thereof
07/10/2003WO2003055462A2 Composition comprising at least an alkanolamide for inhibiting langerhans cell migration, and uses thereof
07/10/2003WO2003055447A2 Heterocyclic acridone inhibitors of impdh enzyme
07/10/2003WO2003055440A2 Compositions and methods for the treatement of immune related diseases
07/10/2003WO2003050119A3 Urea substituted imidazopyridines
07/10/2003WO2003035107A8 Enzyme inhibitors for inactivating allergens
07/10/2003WO2003010140A3 Hepatitis c virus polymerase inhibitors with heterobicyclic structure
07/10/2003WO2003008452A3 Bispecific monoclonal antibodies to il-12 and il-18 receptors
07/10/2003WO2003004511A3 Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals
07/10/2003WO2002100354A8 Pyrrolo[2,3-d]pyrimidine nucleoside analogs
07/10/2003WO2002063008A3 Intracellular signaling molecules
07/10/2003WO2002059267A3 Constitutively desensitized g protein-coupled receptors
07/10/2003WO2002046409A3 Proteins and nucleic acids encoding same
07/10/2003WO2002028408A9 Compositions and methods for the transport of biologically active agents across cellular barriers
07/10/2003WO2002018581A3 G-protein coupled receptors
07/10/2003WO2002013845A3 Inflammation related g-protein coupled receptor
07/10/2003WO2002012281A3 Molecular vaccine linking an endoplasmic reticulum chaperone polypeptide to an antigen
07/10/2003WO2002000730A9 Pd-l2 molecules: novel pd-1 ligands and uses therefor
07/10/2003WO2001098269A3 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
07/10/2003WO2001089549A3 Therapeutic uses of il-1 receptor antagonist
07/10/2003US20030131370 Disruption of the glutathione S-transferase-Omega-1 gene
07/10/2003US20030130518 They induce the biosynthesis of various cytokines and are useful in the treatment of viral and neoplastic diseases.
07/10/2003US20030130517 Useful as antiinflammatory drugs, particularly as remedies for rheumatoid arthritis
07/10/2003US20030130515 Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo[1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity
07/10/2003US20030130486 A fusion proteins having the C-terminal region of the interfero protein is replaced by a C-terminal region of tau proteins; viricides, antiproliferation agents, antiinflammatory agents; lower cytotoxic side effects
07/10/2003US20030130335 Protein tyrosine phosphatases inhibitors
07/10/2003US20030130333 Combination product and methods of use
07/10/2003US20030130299 Administering dosage of immunology response moderator
07/10/2003US20030130298 Autoimmune disease; grafting organs
07/10/2003US20030130292 Immunosuppressants; autoimmune disease; skin disorders; Crohn's disease; antidiabetic agents; anticancer agents; antiarthritic agents
07/10/2003US20030130289 Inhibitors of glycogen synthase kinase 3
07/10/2003US20030130282 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
07/10/2003US20030130277 Pyrazoloquinolinone derivatives as protein kinase C inhibitors
07/10/2003US20030130273 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
07/10/2003US20030130265 Benzimidazole derivatives, a process for their manufacture and use as a medicine
07/10/2003US20030130264 Methods of using pyrimidine-based antiviral agents
07/10/2003US20030130263 Mixture of two antihistamines; sustained release
07/10/2003US20030130257 Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
07/10/2003US20030130254 Respiratory system disorders; antihistamines; antiarthritic agents
07/10/2003US20030130250 Methods to mobilize progenitor/stem cells
07/10/2003US20030130238 Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and tace inhibitors
07/10/2003US20030130235 3-[4-Substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2- indolinone derivatives as kinase inhibitors
07/10/2003US20030130232 Amidine derivatives, the preparation and use thereof as medicaments with LTB4 antagonistic effect
07/10/2003US20030130218 Methods of stimulating phagocytosis
07/10/2003US20030130209 Method of treatment of myocardial infarction
07/10/2003US20030130201 Mixture with ascorbic acid, proline and lysine
07/10/2003US20030130200 Tripeptide or tetrapeptide
07/10/2003US20030130187 Porcine adenovirus type 3 genome
07/10/2003US20030130182 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/10/2003US20030130180 Utilization of an aminopeptidase inhibitor
07/10/2003US20030130176 Spary drying dispersion; antiinflammatory agents; antihistamines; lung diseases
07/10/2003US20030130168 Reverse-turn mimetics and methods relating thereto
07/10/2003US20030129706 Fhm, a novel member of the TNF ligand supergene family
07/10/2003US20030129662 Use of vascular endothelial growth factor (VEGF)
07/10/2003US20030129655 Nucleic acids encoding GTPase activating proteins
07/10/2003US20030129606 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
07/10/2003US20030129266 Interleukin-4 production inhibitors
07/10/2003US20030129265 Interleukin-4 production inhibitors
07/10/2003US20030129251 Polynucleotide of an immunostimulatory sequence linked to a biodegradable microcarrier
07/10/2003US20030129209 Topical application of cetirizine and loratadine
07/10/2003US20030129206 Medicament for the immunotherapy of malignant tumours
07/10/2003US20030129205 Inducing presensitization of immune system towards an immunogen carrying lymphocytes epitope homologous to allergen; immunosuppressants
07/10/2003US20030129199 Combined vaccine compositions
07/10/2003US20030129196 Methods for preparing compositions comprising heat shock proteins or alpha-2-macroglobulin useful for the treatment of cancer and infectious disease
07/10/2003US20030129190 FX activity in cells in cancer, inflammatory responses and diseases and in autoimmunity
07/10/2003US20030129187 Complement pathway inhibitors binding to C5 and C5a without preventing formation of C5b
07/10/2003US20030129181 Hydrolases modified by polyoxyethylene glycol for induction of high plasmatic levels of free tumor necrosis factor
07/10/2003US20030129166 Human circulating dendritic cell compositions and methods
07/10/2003US20030129161 Interleukin-12 as a veterinary vaccine adjuvant
07/10/2003US20030129159 Derivatisation of proteins
07/10/2003US20030129141 Dispersable dry powder; controlling moisture concentration, particle size; in situ drug delivery
07/10/2003US20030129129 Prevention, therapy disease; forming tritiated water; calibration
07/10/2003CA2511466A1 Bacillus subtilis spores to stimulate the immune responses
07/10/2003CA2472121A1 Composition comprising at least an alkanolamide for inhibiting langerhans cell migration, and uses thereof
07/10/2003CA2471713A1 Benzothiazole- and benzoxazole-4,7-dione derivatives and their use as cdc25 phosphatase inhibitors
07/10/2003CA2471647A1 Antibody composition which specifically binds to cd20
07/10/2003CA2471348A1 Quinazolinone derivative
07/10/2003CA2471306A1 Secreted proteins
07/10/2003CA2471297A1 Human netrin receptor and uses thereof
07/10/2003CA2471130A1 Il-17 like molecules and uses thereof
07/10/2003CA2470903A1 A system for stable expression of sirnas in mammalian cells
07/10/2003CA2470781A1 Cystine-knot fold protein
07/10/2003CA2470707A1 Cellular compositions and methods of making and using them
07/10/2003CA2470666A1 Secreted protein
07/10/2003CA2468619A1 Adiponectin fragments and conjugates
07/10/2003CA2458751A1 Compositions and methods for the treatement of immune related diseases
1 ... 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 ... 1172